Outsourcing for the pharmaceutical industry

Welcome to the Dishman Carbogen Amcis Ltd web site. Our organisation is embarking on a new and exciting era; therefore, our online presence is currently undergoing a complete refresh and total restructuring, which will be completed over the next several weeks. 

Please feel free to contact us with any queries or browse this initial preview to our newly refurbished corporate portal.

Our Mission

The mission of Dishman Carbogen Amcis and its fundamental purpose is to offer support and assistance to people across the world suffering from illness and disease; striving to ensure that this is completed efficiently, comprehensively and effectively.

Latest News

  • CARBOGEN AMCIS announces major investments of more than CHF 100 million in Switzerland and France

    News

    CARBOGEN AMCIS announces major investments of more than CHF 100 million in Switzerland and France

    BUBENDORF, Switzerland (August 17, 2020) — Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient...

    Read more

  • Dishman Carbogen Amcis Statement on COVID-19

    News

    Dishman Carbogen Amcis Statement on COVID-19

    Dear Customers and Partners,

    We at Dishman Carbogen Amcis group of companies are taking the risks associated with COVID-19 very seriously, and have already implemented a set of measures aimed at limiting any risk to our employees, customers...

    Read more

  • Successful FDA Inspection at Neuland, Switzerland

    News

    Successful FDA Inspection at Neuland, Switzerland

    BUBENDORF, Switzerland (August 6, 2019) — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announced today its Hunzenschwil (Neuland),...

    Read more

  • ISO22716 Cosmetics GMP standard accreditation

    News

    ISO22716 Cosmetics GMP standard accreditation

    BUBENDORF, Switzerland (May 22nd, 2019) — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announced today that its Manchester site successfully...

    Read more

  • Dishman Carbogen Amcis Ltd. Announces a Successful FDA Inspection of its Site in Bavla, India

    News

    Dishman Carbogen Amcis Ltd. Announces a Successful FDA Inspection of its Site in Bavla, India

    Ahmedabad, India (November 5th, 2018) — India-based Dishman Carbogen Amcis Limited, a global outsourcing partner for the pharmaceutical industry, announced today that its manufacturing and...

    Read more

  • DISHMAN CARBOGEN AMCIS OPENS OFFICE IN KYOTO, JAPAN

    News

    Dishman Carbogen Amcis Opens Office in Kyoto, Japan

    BUBENDORF, Switzerland (August 1st, 2018) — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announced today the opening of their new...

    Read more

    Upcoming events

    • CPhI Worldwide in Milano

      CPhI Worldwide in Milano

      Events

      CPhI Worldwide in Milano

       

      We’re thrilled to announce that CPhI Worldwide will return to Milan from 9th to 11th November 2021.

      Over the last 30+ years, CPhI has provided a unique platform...

      Read more

    • CPhI North America

      CPhI North America

      Events

      CPhI North America

       

      CPhI organizes the most important and widespread series of global pharmaceutical events. Our gatherings are both renowned and revered—but it didn’t start in North America. With massive...

      Read more

    • CPhI China in Shanghai

      CPhI China in Shanghai

      Events

      CPhI China in Shanghai

       

      Each year CPhI unites more than 100,000 pharmaceutical professionals through exhibitions, conferences and online communities to network, identify business opportunities and expand the...

      Read more

    • Chemspec Europe in Cologne

      Chemspec Europe in Cologne

      Events

      Chemspec Europe in Cologne

       

      COVID-19, sustainability, new trends, and digitalisation are not just buzzwords. In fact, these aspects and the ongoing demand for innovations determine the industry. The choice of...

      Read more

      Key Figures

      A global presence with 10 sites in Switzerland, India, UK, France, Netherlands & China
      More than 30 years of experience in clinical API development
      Production from gram to several 1000 kilogrammes scale manufacturing for API production
      More than 1150 m3 of capacity for API production
      Company Profile

      CONTACT US TODAY OR DOWNLOAD
      OUR COMPANY PROFILE BROCHURE
      FOR FURTHER INFORMATION

      SUBSCRIBE TO OUR MAILING LIST FOR THE LATEST NEWS UPDATES